Sign in →

Test Code CKMB Creatine Kinase-MB

Additional Codes

Cerner

NextGen

CKMB2

CKMB2

Alternate Name(s)

CK-MB

Creatine Phosphokinase-MB

CPK-MB

Useful For

Creatine kinase (CK) is a key enzyme of energy metabolism in muscle, catalyzing the reversible physphorylation of creatine.  This dimeric enzyme has two active subunits, M and B, which associate to form three isoenzymes, CK-MM, CK-MB, and CK-BB.  CK-MM is found predominantly in skeletal muscle and CK-BB in brain.  CK-MB is found predominantly in cardiac muscle accounting for approximately 10-40% of myocardial CK.

The low concentration of CK-MB in normal serum and non-cardiac tissues is the basis of its widely accepted use as a diagnostic indicator of myocardial injury.  Damage to the myocardium results in a transient release of CK-MB into the circulation.  This increase in CK-MB reaches a peak in 12 to 24 hours, then returns to normal within 48 to 72 hours. This characteristic temporal pattern is diagnostic for AMI.  Approximately 98% of patients with AMI exhibit elevated serum CK-MB while only 3% of non-AMI patients exhibit abnormal CK-MB.

Methodology

Chemiluminescent Immunometric

Patient Preparation

None

Collection Instructions

Standard phlebotomy practices.

Specimen Requirements

Container

Specimen Type

Tube

Lithium Heparin Plasma

PST

 or  or 

 

Stability

Storage

Temperature

Stability

Room Temperature

18-28°C

≤ 3 hours

Refrigerated

 2-8°C

≤ 5 days

Frozen

≤-20 °C

4 weeks

Thaw 1 time only

Rejection Criteria

Gross Hemolysis

Turbid Specimens

Result Reporting and Reference Values

Reported in ng/mL

No reference range studies for patients <18 years old

Age

Reference Range

18Y-150Y

0.00-3.38

Reflex Testing

None

Limitations

  • Ortho reports a bias with the following:
    • Cefoxitin, Dextran 40, Gamma Globulin can cause a negative bias
  • Ortho reports no significant effect with the following:
    • Bilirubin up to 40 mg/dL
    • Hemoglobin up to 501 mg/dL